Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a **combination drug** composed of **lysozyme**, **cetylpyridine** (commonly used as cetylpyridinium chloride), and **lidocaine**. - **Lidocaine** is an amide-type local anesthetic that blocks sodium channels on neuronal membranes, producing reversible loss of sensation and pain relief at the site of application[5][7]. - **Cetylpyridine** (typically referenced as cetylpyridinium chloride, CPC) is a cationic quaternary ammonium compound with antiseptic, antibacterial, and antiviral properties, commonly used in oral care products for controlling bacterial growth, reducing gingivitis, and treating sore throat[2][4][6]. - **Lysozyme** is an enzyme with natural antibacterial properties, capable of breaking down bacterial cell walls. It is commonly utilized in oral and mucosal treatments for its antimicrobial action (supported by general pharmaceutical literature, but not specifically referenced in the search results). The combination is designed primarily for **oromucosal application**, targeting symptoms such as sore throat, oral pain, minor infections, and oral mucosal lesions. Commonly, such combinations are found in lozenge or gel formulations, with the lidocaine providing rapid local anesthesia and cetylpyridine (chloride) and lysozyme contributing antiseptic and antibacterial effects; the combination is generally regarded as safe for short-term topical oral use[1][2][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on lysozyme + cetylpyridine + lidocaine.